The efficacy and safety of pemetrexed-based doublet therapy compared to pemetrexed alone for the second-line treatment of advanced non-small-cell lung cancer: an updated meta-analysis

BACKGROUND: Pemetrexed is currently recommended as the second-line treatment for patients with advanced non-small-cell lung cancer (NSCLC). However, it is unclear whether pemetrexed-based doublet therapy improves treatment efficacy and safety. Thus, this meta-analysis was performed to resolve this c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Anyuan, Xiong, Xiaolu, Shi, Minhua, Xu, Huajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516195/
https://www.ncbi.nlm.nih.gov/pubmed/26229433
http://dx.doi.org/10.2147/DDDT.S88218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516195/
https://www.ncbi.nlm.nih.gov/pubmed/26229433
http://dx.doi.org/10.2147/DDDT.S88218

Ejemplares similares